AlzeCure Presents Clinical Phase II-Data with ACD440 for Neuropathic Ppain at Pain Conference

AlzeCure Pharma AB announced that the company’s presentation at the pain conference held by the Swedish Pain Society is now available in its entirety on the company’s website.